Brief: Heidelberg Pharma Plans Capital Increase Of Up To 10%

Heidelberg Pharma AG

27/04/2020 16:49

April 27 (Reuters) - HEIDELBERG PHARMA AG  WL6G.DE :
    * PLANS CAPITAL INCREASE TO FUND ITS ATAC DEVELOPMENT
PROGRAM
    * CASH CAPITAL INCREASE OF UP TO 10% USING AUTHORIZED
CAPITAL WITH
SHAREHOLDERS' PREEMPTIVE RIGHTS DISAPPLIED
    * HEIDELBERG PHARMA WILL OFFER UP TO 2,820,961 NEW NO-PAR
VALUE
BEARER SHARES WITH A NOTIONAL INTEREST IN SHARE CAPITAL OF EUR
1.00 EACH
    * INCREASING ITS SHARE CAPITAL FROM EUR 28,209,611.00 BY UP
TO EUR
2,820,961.00 TO UP TO EUR 31,030,572.00
    * SHARES WITH A NOTIONAL INTEREST IN SHARE CAPITAL OF EUR
1.00
EACH AND FULL DIVIDEND RIGHTS AS OF 1 DECEMBER 2018
    * PLANS TO USE PROCEEDS FOR FURTHER DEVELOPMENT AND
MARKETING OF
ATAC TECHNOLOGY, IN PARTICULAR DEVELOPMENT OF ATAC CANDIDATE
HDP-101 UNTIL MID-2021

Source text for Eikon:  ID:nEQbzWSLHa 
Further company coverage:  WL6G.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))